Lessons from oncology AI for GI | Sued for AI malpractice? | The most challenging part of being a GI
Abstract art by Adobe Firefly's Generative AI

Lessons from oncology AI for GI | Sued for AI malpractice? | The most challenging part of being a GI

The most challenging part of being a gastroenterologist?(Becker's GI & Endoscopy)

The data comes from "Physician Compensation Report" for 2023 that surveyed 10,011 physicians across more than 29 specialties. Here is how GIs responded when asked about the most challenging part of their job.


No alt text provided for this image

UHC shelves prior authorization for GI endoscopy; replacement ‘could be as bad or worse’?(Healio)

“UnitedHealthcare’s slap-dash approach to rolling out a policy that will ultimately control patient access to critical, often life-saving, medical procedures flies in the face of common sense and responsible medical practice,” said?Barbara H. Jung, MD, AGAF, president of the AGA.


No alt text provided for this image

Lessons From Oncology – How We Can Better Utilize AI for GI?(HIT Consultant)

The adoption of technology has lagged in GI. As a result, many of the same problems relating to diagnosing, treating, and researching conditions in GI have persisted.


No alt text provided for this image

AHA: Health Insurer Policies Fuel Physician Practice Acquisitions?(RevCycleIntelligence)

Health insurer policies are increasing administrative burden for independent physician practices, pushing them to seek employment in other settings and fueling physician practice acquisitions.


No alt text provided for this image

Will Humira Biosimilars Cause a Wave or a Ripple??(GI & Endoscopy News)

With 2023 poised to be the year of the adalimumab (Humira, AbbVie) biosimilar wave, a new report focuses on market expansion and sustainability for biosimilars in the United States.


No alt text provided for this image

When Could You Be Sued for AI Malpractice? You’re Likely Using It Now?(Medscape)

As hospitals and medical groups deploy AI into more areas of healthcare, new liability exposures may be on the horizon.


No alt text provided for this image

Lucid Diagnostics Launches First EsoGuard? Mobile Test Unit

(PR Newswire)

First esophageal precancer detection event utilizing an EsoGuard mobile test unit to be hosted today by Florida Digestive Health Specialists in Sarasota, Florida.


No alt text provided for this image

Unraveling the Mechanisms Behind FMT Efficacy Needed to Expand Its Use?(Medscape)

A deeper understanding of the mechanisms underlying the success of fecal microbiota transplantation (FMT) is needed to further improve its effectiveness, according to two recent reviews.


No alt text provided for this image

Gastroenterology Practice Expands Specializations and Locations to Become the Premier Digestive Care Clinic of South Texas?(Access Wire)

Building upon the success of its Victoria location, which has been serving the community for nearly a decade, Gastro Health & Nutrition now expands its presence to the Memorial City area of Houston.


No alt text provided for this image

GIE Medical Granted FDA's Breakthrough Device Designation for Multi-Stage Drug Coated Balloon to Treat Esophageal Strictures?(PR Newswire)

GIE Medical, a clinical stage company developing solutions for patients suffering from benign stricture(s) of the esophagus or bowel, was granted designation as a Breakthrough Device from the U.S. Food and Drug Administration (FDA).


No alt text provided for this image

Burned Out, Doctors Turn to Temp Work?(The Wall Street Journal)

A growing group of physicians are ditching medicine’s traditional career path and hitting the road as temporary doctors-for-hire.



No alt text provided for this image

Some Gut Bacteria Linked to Precancerous Colon Polyps?(Harvard Medical School)

A new study by Harvard Medical School investigators at Massachusetts General Hospital has linked certain types of gut bacteria to the development of precancerous colon polyps.


No alt text provided for this image

In IBD, Thromboembolic Events Can Have ‘Catastrophic Consequences’

(Physician’s Weekly)

“The incidence of thrombotic events is three-fold to four-fold higher in patients with IBD compared with patients without IBD,” notes Alfred D. Nelson, MD.


No alt text provided for this image

Grail says about 400 patients incorrectly informed they may have cancer?(Reuters)

Cancer test maker Grail Inc said that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer.


Current Approach to Postoperative Crohn’s Disease

(Gastroenterology & Hepatology)

The highest-risk patients may be on their second, third, fourth, or more surgeries and have already shown recurrence after their first surgery.


Akero says NASH drug shown to reduce liver fat by 65% in some patients?(Reuters)

Akero Therapeutics said that data from a mid-stage study showed its experimental therapy reduced liver fat by 65% in certain patients with a type of fatty liver disease called nonalcoholic steatohepatitis (NASH).


New York-Presbyterian sued after gastroenterologist allegedly assaulted patient?(Becker’s GI & Endoscopy)

New York City-based NewYork-Presbyterian was named in a civil lawsuit that alleges Zhi Alan Cheng, MD, a gastroenterologist who previously practiced at the health system's Flushing, N.Y., location.


For weekly gastroenterology business/tech updates directly in your inbox, subscribe to the?Scope Forward newsletter.

Get the book:?Scope Forward - The Future of Gastroenterology Is Now In Your Hands

要查看或添加评论,请登录

Praveen Suthrum的更多文章

社区洞察

其他会员也浏览了